FDA Shakeup: Vaccine Official Vinay Prasad Resigns Amid Controversy
Vinay Prasad, FDA's top vaccine official, has resigned after three months amid criticism and controversy, especially concerning the FDA's handling of a gene therapy for Duchenne muscular dystrophy. His departure comes amidst debate over his regulatory decisions and political leanings. George Tidmarsh will serve as interim CBER director.
The FDA has experienced another leadership shakeup as Vinay Prasad, its top vaccine official, stepped down after only three months in the role. Prasad faced intense scrutiny, especially over the agency's approach to a gene therapy for Duchenne muscular dystrophy.
Criticism mounted following reports that the FDA-approved therapy was linked to the deaths of two teens. The FDA halted shipments, citing safety concerns, intensifying backlash against Prasad. Political critic Laura Loomer branded him a 'progressive leftist saboteur.'
George Tidmarsh, a recent appointee, will serve as acting CBER director. Industry analyst Joseph Schwartz suggests the resignation, despite adding uncertainty, could alleviate some regulatory risk concerns.
(With inputs from agencies.)
ALSO READ
Demands Grow for Resignation Over Student's Tragic Death
Odisha Political Turmoil: Calls for Chief Minister's Resignation Echo After Tragic Student Death
Trump's Wish for Powell's Resignation Raises Market Concerns
Call for Accountability: Owaisi Demands Resignation of J-K LG Post Pahalgam Attack
Sarepta Defies FDA Order Amidst Gene Therapy Controversies
Google News